These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9392483)

  • 1. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.
    Cetkovic-Cvrlje M; Gerling IC; Muir A; Atkinson MA; Elliott JF; Leiter EH
    Diabetes; 1997 Dec; 46(12):1975-82. PubMed ID: 9392483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
    Gerling IC; Atkinson MA; Leiter EH
    J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
    Gerling IC; Serreze DV; Christianson SW; Leiter EH
    Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
    Overbergh L; Decallonne B; Waer M; Rutgeerts O; Valckx D; Casteels KM; Laureys J; Bouillon R; Mathieu C
    Diabetes; 2000 Aug; 49(8):1301-7. PubMed ID: 10923629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells.
    Bridgett M; Cetkovic-Cvrlje M; O'Rourke R; Shi Y; Narayanswami S; Lambert J; Ramiya V; Baekkeskov S; Leiter EH
    Diabetes; 1998 Dec; 47(12):1848-56. PubMed ID: 9836515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAD65 and insulin B chain peptide (9-23) are not primary autoantigens in the type 1 diabetes syndrome of the BB rat.
    Bieg S; Hanlon C; Hampe CS; Benjamin D; Mahoney CP
    Autoimmunity; 1999; 31(1):15-24. PubMed ID: 10593565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
    Tian J; Atkinson MA; Clare-Salzler M; Herschenfeld A; Forsthuber T; Lehmann PV; Kaufman DL
    J Exp Med; 1996 Apr; 183(4):1561-7. PubMed ID: 8666914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice.
    Ramiya VK; Shang XZ; Wasserfall CH; Maclaren NK
    Autoimmunity; 1997; 26(3):139-51. PubMed ID: 9550282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
    Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
    J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
    Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
    J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
    Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
    J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination.
    Tisch R; Wang B; Weaver DJ; Liu B; Bui T; Arthos J; Serreze DV
    J Immunol; 2001 Feb; 166(3):2122-32. PubMed ID: 11160264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
    J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
    Liu B; Yue Y; Yang Y; Jin Y
    PLoS One; 2016; 11(1):e0147260. PubMed ID: 26783749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.